Apoptosis
Read More about this categoryShow Less
As one of the cellular death mechanisms, apoptosis, also known as programmed cell death, can be defined as the process of a proper death of any cell under certain or necessary conditions. Apoptosis is controlled by the interactions between several molecules and responsible for the elimination of unwanted cells from the body.
Many biochemical events and a series of morphological changes occur at the early stage and increasingly continue till the end of apoptosis process. Morphological event cascade including cytoplasmic filament aggregation, nuclear condensation, cellular fragmentation, and plasma membrane blebbing finally results in the formation of apoptotic bodies. Several biochemical changes such as protein modifications/degradations, DNA and chromatin deteriorations, and synthesis of cell surface markers form morphological process during apoptosis.
Apoptosis can be stimulated by two different pathways: (1) intrinsic pathway (or mitochondria pathway) that mainly occurs via release of cytochrome c from the mitochondria and (2) extrinsic pathway when Fas death receptor is activated by a signal coming from the outside of the cell.
Different gene families such as caspases, inhibitor of apoptosis proteins, B cell lymphoma (Bcl)-2 family, tumor necrosis factor (TNF) receptor gene superfamily, or p53 gene are involved and/or collaborate in the process of apoptosis.
Caspase family comprises conserved cysteine aspartic-specific proteases, and members of caspase family are considerably crucial in the regulation of apoptosis. There are 14 different caspases in mammals, and they are basically classified as the initiators including caspase-2, -8, -9, and -10; and the effectors including caspase-3, -6, -7, and -14; and also the cytokine activators including caspase-1, -4, -5, -11, -12, and -13. In vertebrates, caspase-dependent apoptosis occurs through two main interconnected pathways which are intrinsic and extrinsic pathways. The intrinsic or mitochondrial apoptosis pathway can be activated through various cellular stresses that lead to cytochrome c release from the mitochondria and the formation of the apoptosome, comprised of APAF1, cytochrome c, ATP, and caspase-9, resulting in the activation of caspase-9. Active caspase-9 then initiates apoptosis by cleaving and thereby activating executioner caspases. The extrinsic apoptosis pathway is activated through the binding of a ligand to a death receptor, which in turn leads, with the help of the adapter proteins (FADD/TRADD), to recruitment, dimerization, and activation of caspase-8 (or 10). Active caspase-8 (or 10) then either initiates apoptosis directly by cleaving and thereby activating executioner caspase (-3, -6, -7), or activates the intrinsic apoptotic pathway through cleavage of BID to induce efficient cell death. In a heat shock-induced death, caspase-2 induces apoptosis via cleavage of Bid.
Bcl-2 family members are divided into three subfamilies including (i) pro-survival subfamily members (Bcl-2, Bcl-xl, Bcl-W, MCL1, and BFL1/A1), (ii) BH3-only subfamily members (Bad, Bim, Noxa, and Puma9), and (iii) pro-apoptotic mediator subfamily members (Bax and Bak). Following activation of the intrinsic pathway by cellular stress, pro‑apoptotic BCL‑2 homology 3 (BH3)‑only proteins inhibit the anti‑apoptotic proteins Bcl‑2, Bcl-xl, Bcl‑W and MCL1. The subsequent activation and oligomerization of the Bak and Bax result in mitochondrial outer membrane permeabilization (MOMP). This results in the release of cytochrome c and SMAC from the mitochondria. Cytochrome c forms a complex with caspase-9 and APAF1, which leads to the activation of caspase-9. Caspase-9 then activates caspase-3 and caspase-7, resulting in cell death. Inhibition of this process by anti‑apoptotic Bcl‑2 proteins occurs via sequestration of pro‑apoptotic proteins through binding to their BH3 motifs.
One of the most important ways of triggering apoptosis is mediated through death receptors (DRs), which are classified in TNF superfamily. There exist six DRs: DR1 (also called TNFR1); DR2 (also called Fas); DR3, to which VEGI binds; DR4 and DR5, to which TRAIL binds; and DR6, no ligand has yet been identified that binds to DR6. The induction of apoptosis by TNF ligands is initiated by binding to their specific DRs, such as TNFα/TNFR1, FasL /Fas (CD95, DR2), TRAIL (Apo2L)/DR4 (TRAIL-R1) or DR5 (TRAIL-R2). When TNF-α binds to TNFR1, it recruits a protein called TNFR-associated death domain (TRADD) through its death domain (DD). TRADD then recruits a protein called Fas-associated protein with death domain (FADD), which then sequentially activates caspase-8 and caspase-3, and thus apoptosis. Alternatively, TNF-α can activate mitochondria to sequentially release ROS, cytochrome c, and Bax, leading to activation of caspase-9 and caspase-3 and thus apoptosis. Some of the miRNAs can inhibit apoptosis by targeting the death-receptor pathway including miR-21, miR-24, and miR-200c.
p53 has the ability to activate intrinsic and extrinsic pathways of apoptosis by inducing transcription of several proteins like Puma, Bid, Bax, TRAIL-R2, and CD95.
Some inhibitors of apoptosis proteins (IAPs) can inhibit apoptosis indirectly (such as cIAP1/BIRC2, cIAP2/BIRC3) or inhibit caspase directly, such as XIAP/BIRC4 (inhibits caspase-3, -7, -9), and Bruce/BIRC6 (inhibits caspase-3, -6, -7, -8, -9).
Any alterations or abnormalities occurring in apoptotic processes contribute to development of human diseases and malignancies especially cancer.
References:
1.Yağmur Kiraz, Aysun Adan, Melis Kartal Yandim, et al. Major apoptotic mechanisms and genes involved in apoptosis[J]. Tumor Biology, 2016, 37(7):8471.
2.Aggarwal B B, Gupta S C, Kim J H. Historical perspectives on tumor necrosis factor and its superfamily: 25 years later, a golden journey.[J]. Blood, 2012, 119(3):651.
3.Ashkenazi A, Fairbrother W J, Leverson J D, et al. From basic apoptosis discoveries to advanced selective BCL-2 family inhibitors[J]. Nature Reviews Drug Discovery, 2017.
4.McIlwain D R, Berger T, Mak T W. Caspase functions in cell death and disease[J]. Cold Spring Harbor perspectives in biology, 2013, 5(4): a008656.
5.Ola M S, Nawaz M, Ahsan H. Role of Bcl-2 family proteins and caspases in the regulation of apoptosis[J]. Molecular and cellular biochemistry, 2011, 351(1-2): 41-58.
Research Areas
- Caspase(143)
- Pyroptosis(42)
- 14.3.3 Proteins(1)
- Apoptosis Inducers(42)
- Bax(6)
- Bcl-2 Family(188)
- Bcl-xL(8)
- c-RET(8)
- IAP(33)
- KEAP1-Nrf2(87)
- MDM2(12)
- p53(153)
- PC-PLC(4)
- PKD(7)
- RasGAP (Ras- P21)(1)
- Survivin(13)
- Thymidylate Synthase(12)
- TNF-α(255)
- Other Apoptosis(877)
- APC(6)
- PD-1/PD-L1 interaction(131)
- ASK1(4)
- PAR4(2)
- RIP kinase(57)
- FKBP(25)
- Cuproptosis(4)
Products Related to Apoptosis(3359)
- GC718335-Aminolevulinic acid-d2 hydrochlorideCAS: 187237-35-0Purity: >91.00%
5-Aminolevulinic acid-d2 hydrochloride 는 듀테륨 표기된 5-아미노펜산염산염이다.
- GC71915Tanshinone IIBCAS: 17397-93-2Purity: >99.00%
Tanshinone IIB는 아시아 국가에서 뇌졸중 및 관상 동맥 심장 질환의 연구에 널리 사용되는 Salvia miltiorrhiza (Danshen) 뿌리의 주요 활성 구성 물질입니다.
- GC71997Alphitolic acidCAS: 19533-92-7Purity: >98.00%
Alphitolic acid는 루판체 구조를 가진 사이클릭 트리테르페노이드인 항염증 및 세포 독성 활성을 나타낸다.
- GC72001PhellamurinCAS: 52589-11-4
Phellamurin은 Phellodendron amurense의 잎에서 추출한 식물 flavonone glycoside 이며 장내 P-glycoprotein을 억제한다.
- GC72012DehydrocrenatidineCAS: 65236-62-6Purity: >98.00%
Dehydrocrenatidine는 천연 알칼리의 일종이며 특정 JAK 억제제입니다.
- GC72018GoniothalaminCAS: 17303-67-2Purity: >98.00%
Goniothalamin (GTN) 는 항암, 항염 및 면역 억제 특성을 가진 스티렌 메타네이트입니다.
- GC72147Mca-YVADAP-Lys(Dnp)-OH TFAPurity: >98.00%
Mca-YVADAP-Lys(Dnp)-OH TFA는 카스파제1 및 안지오텐신 전환 효소 2 ACE2의 불소 생성 기질입니다.
- GC72183[D-Leu-4]-OB3CAS: 289056-32-2Purity: >99.00%
[D-Leu-4]-OB3은 pro-inflammatory, proliferation and metastatic genes 및 pd-l1expression의 발현을 억제한다.
- GC72186WLSEAGPVVTVRALRGTGSWCAS: 771479-86-8Purity: >96.00%
WLSEAGPVVTVRALRGTGSW 는 심근세포 특이성 펩타이드의 일종이다.
- GC72216(Gly14)-Humanin (human) (acetate)Purity: >98.00%
(Gly14)-Humanin (human) (acetate) 는 Humanin의 유사 물질로 이 중 14 번째 아미노산 실크 아미노산이 글리 (Gly) 로 대체되었습니다.
- GC72251Tripeptide-32CAS: 1185583-20-3Purity: >99.00%
Tripeptide-32 는 안티에이징 효과가 있는 바이오 활성 펩타이드로 화장품 성분으로 보도되었습니다.
- GC72318TulisokibartCAS: 2648504-55-4Purity: 95.00%
Tulisokibart (PRA023)는 서였 IgG1-단일 클론 항체 κ TNFSF15/TL1A을 겨냥하고 있다.
- GC72337Anti-Mouse 4-1BB/CD137 Antibody (3H3)Purity: >99.00%
Anti-Mouse 4-1BB/CD137 Antibody (3H3) 숙주 쥐에서 유래한 항생쥐 4-1BB IgG2a 항체 억제제입니다.
- GC72359QuilizumabCAS: 1228538-47-3Purity: >96.00%
Quilizumab (항인 NGcGM3 재조합 항체) 는 일종의 인원화 IgG1 단일 클론 항체이다.
- GC72360RuplizumabCAS: 220651-94-5Purity: >99.00%
Ruplizumab (BG 9588) 는 휴머노이드 단일 클론 항 CD40L (TNF 수용체) IgG1 항체이다.
- GC72364ToralizumabCAS: 252662-47-8Purity: 95.00%
Toralizumab (IDEC-131) 는 CD40L (CD154) 에 대한 인간화 단클론항체 (mAb) 로 인간감마1중사슬과 인간감마경사슬로 구성되어 있다.
- GC72365VisilizumabCAS: 219716-33-3Purity: >98.00%
Visilizumab (항인 CD3E 재조합 항체) 는 인간화된 저Fc 수용체가 결합된 항CD3 단일클론 IgG2 항체이다.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC71833 | 5-Aminolevulinic acid-d2 hydrochloride | 187237-35-0 | >91.00% | |
5-Aminolevulinic acid-d2 hydrochloride 는 듀테륨 표기된 5-아미노펜산염산염이다. | ||||
| GC71915 | Tanshinone IIB | 17397-93-2 | >99.00% | |
Tanshinone IIB는 아시아 국가에서 뇌졸중 및 관상 동맥 심장 질환의 연구에 널리 사용되는 Salvia miltiorrhiza (Danshen) 뿌리의 주요 활성 구성 물질입니다. | ||||
| GC71968 | Celosin K | 1950579-53-9 | >99.00% | |
Celosin K (화합물 8)는 등나무 씨앗에서 분리 될 수 있습니다. | ||||
| GC71997 | Alphitolic acid | 19533-92-7 | >98.00% | |
Alphitolic acid는 루판체 구조를 가진 사이클릭 트리테르페노이드인 항염증 및 세포 독성 활성을 나타낸다. | ||||
| GC72001 | Phellamurin | 52589-11-4 | - | |
Phellamurin은 Phellodendron amurense의 잎에서 추출한 식물 flavonone glycoside 이며 장내 P-glycoprotein을 억제한다. | ||||
| GC72012 | Dehydrocrenatidine | 65236-62-6 | >98.00% | |
Dehydrocrenatidine는 천연 알칼리의 일종이며 특정 JAK 억제제입니다. | ||||
| GC72018 | Goniothalamin | 17303-67-2 | >98.00% | |
Goniothalamin (GTN) 는 항암, 항염 및 면역 억제 특성을 가진 스티렌 메타네이트입니다. | ||||
| GC72054 | Obovatol | 83864-78-2 | >99.00% | |
Obovatol 는 후박한 잎에서 분리된 페닐에테르 목지소의 일종이다. | ||||
| GC72061 | β-Phellandrene | 555-10-2 | >99.50% | |
β-Phellandrene 바위뼈에서 얻었습니다. | ||||
| GC72103 | Kp7-6 | 629628-53-1 | >98.00% | |
Fas 모방 펩타이드인 Kp7-6는 Fas/FasL 길항제이다. | ||||
| GC72146 | WP9QY TFA | - | >99.00% | |
WP9QY TFATNF-a 옹색제는 생물 활성 펩타이드의 일종이다. | ||||
| GC72147 | Mca-YVADAP-Lys(Dnp)-OH TFA | - | >98.00% | |
Mca-YVADAP-Lys(Dnp)-OH TFA는 카스파제1 및 안지오텐신 전환 효소 2 ACE2의 불소 생성 기질입니다. | ||||
| GC72183 | [D-Leu-4]-OB3 | 289056-32-2 | >99.00% | |
[D-Leu-4]-OB3은 pro-inflammatory, proliferation and metastatic genes 및 pd-l1expression의 발현을 억제한다. | ||||
| GC72186 | WLSEAGPVVTVRALRGTGSW | 771479-86-8 | >96.00% | |
WLSEAGPVVTVRALRGTGSW 는 심근세포 특이성 펩타이드의 일종이다. | ||||
| GC72191 | Pep19-2.5 | 1322711-38-5 | >98.00% | |
Pep19-2.5는 합성 및 항독소 펩타이드로, 세포 내 독소 신호 폭주를 차단합니다. | ||||
| GC72216 | (Gly14)-Humanin (human) (acetate) | - | >98.00% | |
(Gly14)-Humanin (human) (acetate) 는 Humanin의 유사 물질로 이 중 14 번째 아미노산 실크 아미노산이 글리 (Gly) 로 대체되었습니다. | ||||
| GC72251 | Tripeptide-32 | 1185583-20-3 | >99.00% | |
Tripeptide-32 는 안티에이징 효과가 있는 바이오 활성 펩타이드로 화장품 성분으로 보도되었습니다. | ||||
| GC72318 | Tulisokibart | 2648504-55-4 | 95.00% | |
Tulisokibart (PRA023)는 서였 IgG1-단일 클론 항체 κ TNFSF15/TL1A을 겨냥하고 있다. | ||||
| GC72319 | Atrosab | 1365659-05-7 | >96.00% | |
Atrosab는 IgG1 옹색성 항TNFR1 항체의 일종이다. | ||||
| GC72337 | Anti-Mouse 4-1BB/CD137 Antibody (3H3) | - | >99.00% | |
Anti-Mouse 4-1BB/CD137 Antibody (3H3) 숙주 쥐에서 유래한 항생쥐 4-1BB IgG2a 항체 억제제입니다. | ||||
| GC72359 | Quilizumab | 1228538-47-3 | >96.00% | |
Quilizumab (항인 NGcGM3 재조합 항체) 는 일종의 인원화 IgG1 단일 클론 항체이다. | ||||
| GC72360 | Ruplizumab | 220651-94-5 | >99.00% | |
Ruplizumab (BG 9588) 는 휴머노이드 단일 클론 항 CD40L (TNF 수용체) IgG1 항체이다. | ||||
| GC72364 | Toralizumab | 252662-47-8 | 95.00% | |
Toralizumab (IDEC-131) 는 CD40L (CD154) 에 대한 인간화 단클론항체 (mAb) 로 인간감마1중사슬과 인간감마경사슬로 구성되어 있다. | ||||
| GC72365 | Visilizumab | 219716-33-3 | >98.00% | |
Visilizumab (항인 CD3E 재조합 항체) 는 인간화된 저Fc 수용체가 결합된 항CD3 단일클론 IgG2 항체이다. | ||||
